Logo-npj
Submitted: 10 Jul 2023
Accepted: 25 Aug 2023
ePublished: 23 Sep 2023
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2024;13(1): e10642.
doi: 10.34172/npj.2023.10642
  Abstract View: 916
  PDF Download: 245

Hypothesis

Cancer in IgA nephropathy; a letter to the editor on current findings

Maryam ALem 1 ORCID logo, Mahoor Abedzadeh 1 ORCID logo, Zahra Golestani Hotkani 2 ORCID logo, Parham Mashouf 1 ORCID logo, Neda Kianpour 3 ORCID logo, Leila ALem 1* ORCID logo

1 Nickan Research Institute, Isfahan, Iran
2 Department of Bioscience, University of Milan, 20133 Milan, Italy
3 Department of Biotechnology, Biohouse, Inland Norway University of Applied Sciences, Hamar, Hedmark, Norway
*Corresponding Author: Leila ALem, Email: leilaalem916@gmail.com

Implication for health policy/practice/research/medical education:

Recent studies have found no conclusive evidence to suggest an increased risk of cancer in immunoglobulin A nephropathy.

Please cite this paper as: ALem M, Abedzadeh M, Golestani Hotkani Z, Mashouf P, Kianpour N, ALem L. Cancer in IgA nephropathy; a letter to the editor on current findings. J Nephropharmacol. 2024;13(1):e10642. DOI: 10.34172/npj.2023.10642.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 917

Your browser does not support the canvas element.


PDF Download: 245

Your browser does not support the canvas element.